These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17926831)

  • 41. Is prostate cancer screening justified in the Bedouin population?
    Abdallah M; Lazarev I; Ariad S; Mermershtain W
    Onkologie; 2009 May; 32(5):260-2. PubMed ID: 19420972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
    Howard K; Barratt A; Mann GJ; Patel MI
    Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ASCO highlights new findings on cancer screening. Discoveries connected to ovarian, cervical, and prostate cancers.
    Printz C
    Cancer; 2011 Aug; 117(16):3627-9. PubMed ID: 21815131
    [No Abstract]   [Full Text] [Related]  

  • 44. Weighing the benefits and downsides of prostate-specific antigen screening.
    Pignone M
    Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategies for ovarian cancer prevention.
    Dann RB; Kelley JL; Zorn KK
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic services for hereditary breast/ovarian and colorectal cancers - physicians' awareness, use and satisfaction.
    Carroll JC; Cappelli M; Miller F; Wilson BJ; Grunfeld E; Peeters C; Hunter AG; Gilpin C; Prakash P
    Community Genet; 2008; 11(1):43-51. PubMed ID: 18196917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate health: definitely a men's health issue.
    Porche DJ
    Am J Mens Health; 2008 Jun; 2(2):105. PubMed ID: 19477774
    [No Abstract]   [Full Text] [Related]  

  • 50. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hidden killer.
    Healy M
    Nurs Times; 1997 Oct 1-7; 93(40):31-2. PubMed ID: 9386482
    [No Abstract]   [Full Text] [Related]  

  • 52. Risk assessment for ovarian carcinoma: hope or hype?
    Javitt MC
    AJR Am J Roentgenol; 2010 Feb; 194(2):308. PubMed ID: 20093588
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of common seric tumor markers in patients with solid cancers.
    Gara S; Boussen H; Ghanem A; Guemira F
    Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial: March 2022: Ovarian and prostate cancer awareness month.
    Di Donato M
    Front Endocrinol (Lausanne); 2023; 14():1133963. PubMed ID: 36860370
    [No Abstract]   [Full Text] [Related]  

  • 55. An object lesson: source determines the relations that trait anxiety, prostate cancer worry, and screening fear hold with prostate screening frequency.
    Consedine NS; Adjei BA; Ramirez PM; McKiernan JM
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1631-9. PubMed ID: 18628414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian cancer strategies for nurse practitioners.
    Seiser BV
    J Am Acad Nurse Pract; 2001 Aug; 13(8):359-63. PubMed ID: 11930570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
    Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
    Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
    [No Abstract]   [Full Text] [Related]  

  • 58. 15-year followup of a population based prostate cancer screening study.
    Kjellman A; Akre O; Norming U; Törnblom M; Gustafsson O
    J Urol; 2009 Apr; 181(4):1615-21; discussion 1621. PubMed ID: 19233435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Problems of organized fight against malignant tumors].
    Fremmer JE
    Cesk Zdrav; 1972 Feb; 20(2):49-55. PubMed ID: 5059900
    [No Abstract]   [Full Text] [Related]  

  • 60. Ovarian cancer screening.
    Allen DM
    CMAJ; 2005 Feb; 172(4):447. PubMed ID: 15710917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.